Volume Alert - GLW 20.48 Corning Inc $GLW Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GLW 20.48 Corning Inc $GLW Hit a high today of 20.72 Closing the day 10:30 at 20.48 -0.23 -1.11% With a day low of 20.48 and a total volume of 1,378,008.

GLW Recent Posts: http://investorshangout.com/Corning-Inc-GLW-51164/

GLW Corning Inc Recent Headline News

Nexus 6 Review: The Best Android Phone Ever If You Can Find One
at The Street - Wed Nov 12, 12:28PM CST
Motorola-made, with a 6-inch display, it's the first phone to ship with the Android 5.0 Lollipop operating system.
FB: 74.20 (-0.52), SNE: 20.42 (-0.21), GLW: 20.28 (-0.43), GOOG: 546.16 (-1.15), NFLX: 380.62 (-3.24), T: 35.67 (+0.27), S: 5.01 (+0.01), QCOM: 70.59 (+0.30), TMUS: 28.13 (-0.23), TWC: 140.81 (+4.33), TWTR: 41.34 (-1.20), VZ: 50.90 (+0.08), AAPL: 113.07 (+1.82), USM: 38.50 (-0.57)

Corning partners with Zhone for fiber/wireless enterprise solution
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:34AM CST

GLW: 20.28 (-0.43), ZHNE: 2.38 (-0.09)

5 Things Corning Incorporated's Management Wants You to Know
Steve Symington, The Motley Fool - Motley Fool - Wed Nov 12, 11:30AM CST
Credit: Corning Incorporated. Corning reported third-quarter results two weeks ago, and it's no surprise the stock is up around 10% since then. The 163-year-old glass maker beat analysts' expectations on both the top and bottom line: Revenue...
GLW: 20.28 (-0.43), AAPL: 113.09 (+1.84)

Corning and Zhone Technologies to Deliver Enterprise-Ready, All-Fiber Networks
Thomson Reuters ONE - Wed Nov 12, 8:04AM CST
News Release
GLW: 20.28 (-0.43), ZHNE: 2.38 (-0.09)

Optical Communications Segment Will Drive Future Growth For Corning
IAEResearch - at Seeking Alpha - Wed Nov 12, 4:40AM CST

GLW: 20.28 (-0.43)

Upgrade Alert for Corning (GLW)
Comtex SmarTrend(R) - Tue Nov 11, 7:03AM CST
Corning (NYSE:GLW) was upgraded from Hold to Buy at Standpoint Research today. The stock closed yesterday at $20.80 on volume of 6.1 million shares, below average daily volume of 9.4 million. Potential upside of 5.5% exists for Corning, based on a current level of $20.80 and analysts' average consensus price target of $21.94. Corning shares have support at the 200-day moving average (MA) of $20.30 and additional support at the 50-day MA of $19.69.
GLW: 20.28 (-0.43)

Top 10 Net Payout Yield Stocks For November 2014
Stone Fox Capital - Seeking Alpha - Mon Nov 10, 3:02PM CST
This article is a continuation of a monthly series highlighting the top net payout yield (NPY) stocks that was started back in June 2012 (see article ) and explained in August 2012 (see article ). The series highlights the best stocks for...
MPC: 93.08 (-1.93), IBM: 162.18 (+0.26), CF: 266.38 (unch), NOC: 137.15 (+1.13), STX: 62.09 (-0.23), IR: 62.51 (-0.49), SDRL: 20.54 (-0.73), GLW: 20.28 (-0.43), ITW: 92.80 (-0.43), HIG: 39.71 (-0.25), TRV: 103.05 (-0.01)

Watch for Shares of Corning (GLW) to Approach Resistance at $20.90
Comtex SmarTrend(R) - Mon Nov 10, 1:08PM CST
Shares of Corning (NYSE:GLW) have bullishly opened above the pivot of $20.59 today and have reached the first resistance level of $20.72. Analysts will be watching for a cross of the next upside pivot targets of $20.90 and $21.21.
GLW: 20.28 (-0.43)

Corning Earnings In Retrospect: Up 4.8% in the Last 13 Days (GLW)
Comtex SmarTrend(R) - Mon Nov 10, 11:13AM CST
13 days ago, on October 28th, 2014, Corning (NYSE:GLW) reported its earnings. Analysts, on average, expected earnings of $0.38 per share on sales of $2.6 billion. The company actually reported EPS of $0.40 on sales of $2.5 billion, beating EPS estimates by $0.02 and missing revenue estimates by $84.8 million. Since the company's report, shares of Corning have risen from $19.60 to $20.55, representing a gain of 4.8% in the past 13 days.
GLW: 20.28 (-0.43)


Scientist who developed CorningWare dies in NY
By DAVID PITT - AP - Fri Nov 07, 9:02AM CST
DES MOINES, Iowa (AP) — S. Donald Stookey was a young scientist researching the properties of glass in 1952 when he put a glass plate into an oven to heat it. But the oven malfunctioned.
GLW: 20.28 (-0.43)

I'm Finally Buying Corning Stock -- Here's Why
Brian Nichols, The Motley Fool - Motley Fool - Thu Nov 06, 9:44AM CST
There's nothing sexy about Corning . Mostly, it makes glass. But, the glass business is better than most might think, especially when that glass rarely breaks, is combined with technology to make it super-thin, and is economically friendly....
GLW: 20.28 (-0.43), AAPL: 113.09 (+1.84)

Pre-Market Review on Electronic Components Equities -- InvenSense, Corning, Amphenol, Knowles, and Universal Display
PR Newswire - Wed Nov 05, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: InvenSense Inc. (NYSE: INVN), Corning Inc. (NYSE: GLW), Amphenol Corporation (NYSE: APH), Knowles Corporation (NYSE: KN), and Universal Display Corporation (NYSE: OLED). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, November 04, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,383.84, up 0.10% and the NASDAQ Composite closed at 4,623.64, down 0.33%. The S&P 500 finished the session 0.28% lower at 2,012.10. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Information Technology Sector Index ended the day at 673.86, up 0.05%, with the index advancing 4.80% in the previous three months. Register for your complimentary reports on these five stocks at:
OLED: 27.67 (+0.21), APH: 50.47 (-0.80), KN: 19.40 (+0.39), INVN: 14.19 (-0.07), GLW: 20.28 (-0.43)

Downgrade Alert for Corning (GLW)
Comtex SmarTrend(R) - Wed Nov 05, 7:01AM CST
Corning (NYSE:GLW) was downgraded from Buy to Hold at Standpoint Research today. The stock closed yesterday at $20.68 on volume of 11.0 million shares, above average daily volume of 9.2 million. Over the past year, Corning has traded in a range of $16.22 to $22.37 and closed yesterday at $20.68, 27% above that low. The 200-day and 50-day moving averages have moved 0.14% higher and 0.02% lower over the past week, respectively.
GLW: 20.28 (-0.43)

Corning Expands Science & Technology Presence in Korea
Thomson Reuters ONE - Tue Nov 04, 8:45AM CST
Corning Technology Center to focus on advanced glass and ceramic technology development
GLW: 20.28 (-0.43)

Google Nexus 9 Tablet Review: Sleek, Speedy and Lightweight
at The Street - Mon Nov 03, 12:00PM CST
Nexus 9 challenges Apple iPad Air 2 for sleek, speedy and lightweight tablet title.
T: 35.67 (+0.27), AMZN: 315.56 (+4.05), S: 5.01 (+0.01), GME: 44.23 (+0.82), BBY: 35.38 (+0.18), TWC: 140.80 (+4.32), TMUS: 28.13 (-0.23), GLW: 20.28 (-0.43), VZ: 50.91 (+0.09), GOOG: 546.25 (-1.06), AAPL: 113.09 (+1.84), NVDA: 19.49 (-0.16)

Corning (GLW) Crosses Pivot Point Resistance at $20.56
Comtex SmarTrend(R) - Mon Nov 03, 9:01AM CST
Corning (NYSE:GLW) has opened bullishly above the pivot of $20.38 today and has reached the first level of resistance at $20.56. Should the shares continue to rise, the resistance pivots of $20.70 and $21.02 will be of interest.
GLW: 20.28 (-0.43)

Amazon's Kindle Fire 6 Review: Designed to Fit Small Hands, Large Pockets
at The Street - Mon Nov 03, 8:26AM CST
The device's biggest feature is its small price. You can buy one for just under $100.
AMZN: 315.56 (+4.05), GLW: 20.28 (-0.43), MSFT: 49.49 (+0.71), GOOG: 546.25 (-1.06), AAPL: 113.09 (+1.84)

Corning CEO Receives Highest Honor from Korea's Ministry of Trade, Industry, and Energy
Thomson Reuters ONE - Mon Nov 03, 8:01AM CST

GLW: 20.28 (-0.43)

Maxwell Technologies: Guidance Up, Substance Disappoints
Long Only - at Seeking Alpha - Sun Nov 02, 6:42AM CST

MXWL: 11.00 (+0.08), GLW: 20.28 (-0.43)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading